Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles

hCG Clinical Trial

Official title:
Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles

Status Completed

Clinical Trial Summary

Successful embryo implantation is complicated process that requires synchrony between good-quality embryos and receptive endometrium. Human chorionic gonadotropin (hCG), is one of the initial embryonic signals and the major embryoendometrial relationship regulator. This study will be conducted to to investigate the role of parenteral hCG used for the transfer of cryopreserved- thawed embryos with HRT cycles in the outcome of artificially prepared frozen embryo transfer (FET) cycles.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05340010
Study type	Interventional
Source	Alexandria University
Contact
Status	Completed
Phase	Phase 4
Start date	January 1, 2020
Completion date	July 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02427529` - Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD)	Phase 1/Phase 2
Completed	`NCT02763176` - Measuring hCG Levels in Pregnant Women
Completed	`NCT01390207` - Earlier Triggering in Rec-FSH/GnRH Antagonist Cycles	Phase 2/Phase 3
Completed	`NCT04744519` - hCG Concentration in Peripheral Maternal Blood After Embryo Transfer, Ongoing Pregnancy Rates, and Morphokinetics
Completed	`NCT04417569` - A Proof of Concept Study of Serum Progesterone Levels for IVF/ICSI Following HCG Trigger for Oocyte Maturation
Completed	`NCT03495609` - Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers	Phase 4